Document Detail

Effect of alkylphospholipids on Candida albicans biofilm formation and maturation.
MedLine Citation:
PMID:  22995097     Owner:  NLM     Status:  Publisher    
OBJECTIVES: The aim of this study was to evaluate miltefosine and four synthetic compounds (TCAN26, TC19, TC106 and TC117) for their in vitro inhibitory activity against Candida albicans planktonic and biofilm cells and investigate whether these compounds are able to inhibit the biofilm formation and to reduce the viability of mature C. albicans biofilm cells. METHODS: The XTT reduction assay and transmission and scanning electron microscopy were employed to determine the inhibitory effects of the test compounds in comparison with amphotericin B and fluconazole against both planktonic cells and sessile cells in biofilms. RESULTS: C. albicans planktonic cells were susceptible to miltefosine, TCAN26 and TC19, all alkylphospholipid compounds. Miltefosine and TCAN26 present a fungicidal activity with similar values of MIC and minimum fungicidal concentration (MFC), ranging from 2 to 8 mg/L. Cell treatment with sub-inhibitory concentrations of alkylphospholipids induced several ultrastructural alterations. In relation to biofilms, miltefosine reduced formation (38%-71%) and mature biofilms viability (32%-44%), at concentrations of 64 mg/L. TCAN26 also reduced biofilm formation (24%-30%) and mature biofilm viability (15%-20%), at concentrations of 64 mg/L. Although amphotericin B reduced biofilm formation similarly to miltefosine (51%-74%), its activity was lower on mature biofilms (24%-30%). Miltefosine antibiofilm activity was significantly higher than amphotericin B, on both formation and mature biofilms (P<0.05 and P<0.0001, respectively). Fluconazole was the least effective compound tested. CONCLUSION: Promising antibiofilm activity was displayed by miltefosine and other alkylphosphocholine compounds, which could be considered a putative option for future treatment of candidaemia associated with biofilm formation, although further evaluation in in vivo systems is required.
Taissa V M Vila; Kelly Ishida; Wanderley de Souza; Kyriakos Prousis; Theodora Calogeropoulou; Sonia Rozental
Related Documents :
23847767 - Expression and regulation of the endogenous retrovirus 3 in hodgkin's lymphoma cells.
24550157 - A knock-in foxj1 (creert2::gfp) mouse for recombination in epithelial cells with motile...
23906837 - Quantification of shape and cell polarity reveals a novel mechanism underlying malforma...
23844407 - Reproductive cycle of marphysa sanguinea (montagu, 1815) (polychaeta: eunicidae) in the...
19094057 - Amperometric measurements of catecholamine release from single vesicles in mn9d cells.
12930727 - Cholesterol side-chain cleavage cytochrome p450 and 3beta-hydroxysteroid dehydrogenase ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-19
Journal Detail:
Title:  The Journal of antimicrobial chemotherapy     Volume:  -     ISSN:  1460-2091     ISO Abbreviation:  J. Antimicrob. Chemother.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7513617     Medline TA:  J Antimicrob Chemother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Laboratório de Biologia Celular de Fungos, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Avenida Carlos Chagas Filho 373, Bloco C/sub-solo, Sala C0-026, Cidade Universitária, 21.941-902, Rio de Janeiro/RJ, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Differences in taste sensitivity between obese and non-obese children and adolescents.
Next Document:  Breast cancer screening: are we seeing the benefit?